Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Experimental & Molecular Medicine|June 30, 2024
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncologyLucie Thorel, Marion Perréard, Romane Florent, et al.
Frontiers in Immunology|November 22, 2019
The NF-κB RelA Transcription Factor Is Critical for Regulatory T Cell Activation and StabilityEmilie Ronin, Martina Lubrano di Ricco, Romain Vallion, et al.
European Journal of Immunology|February 4, 2020
Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-κBMartina Lubrano di Ricco, Emilie Ronin, Davi Collares, et al.
BMJ Open|April 7, 2026
Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature reviewJonaz Font, Charles Dolladille, Jordane Divoux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2020
Regulatory T Cell Stability and Migration Are Dependent on mTORRomain Vallion, Jordane Divoux, Salomé Glauzy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 5, 2025
Use of patient-derived tumor organoids from head and neck squamous cell carcinoma for the evaluation of the differential effect of carbon ions over X-raysMarion Perréard, Romane Florent, Jordane Divoux, et al.
Cell Death & Disease|March 28, 2026
UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer cells and patient-derived tumor organoidsSahra Messaoudi, Romane Florent, Louis-Bastien Weiswald, et al.
Molecular Metabolism|February 6, 2021
Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasisSéverine Olivier, Camille Pochard, Hanna Diounou, et al.
BMC Cancer|September 19, 2023
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancerJordane Divoux, Romane Florent, Margaux Jacobs, et al.
BMC Cancer|March 9, 2023
ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapiesMarion Perréard, Romane Florent, Jordane Divoux, et al.
Pageof 2